DUSP18 and cancer: Notably, tumor cells defective in DUSP18 or lanosterol do not present growth limitations in vitro or in immunodeficient mice, indicating that DUSP18 or lanosterol is not necessarily required for tumor cell growth and thereby further supporting the idea that its function in the context of cancer is an immunomodulatory one.